Revenue Breakdown
Composition ()
No data
Revenue Streams
Mesa Laboratories Inc (MLAB) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Discrete Revenues- Consumables, accounting for 55.0% of total sales, equivalent to $33.38M. Other significant revenue streams include Discrete Revenues- Hardware and Software and Contracted Revenues- Services. Understanding this composition is critical for investors evaluating how MLAB navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Mesa Laboratories Inc maintains a gross margin of 64.18%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.25%, while the net margin is 5.57%. These profitability ratios, combined with a Return on Equity (ROE) of 2.18%, provide a clear picture of how effectively MLAB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, MLAB competes directly with industry leaders such as OFIX and VREX. With a market capitalization of $515.13M, it holds a significant position in the sector. When comparing efficiency, MLAB's gross margin of 64.18% stands against OFIX's 69.70% and VREX's 33.30%. Such benchmarking helps identify whether Mesa Laboratories Inc is trading at a premium or discount relative to its financial performance.
